Articles tagged "Monitoring"

2018 American Transplant Congress
Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients
E. Tang, A. Bansal, S. Cao, M. Li, M. Novak, I. Mucsi.
University Health Network, Toronto, Canada.
Background: The Patient Reported Outcomes Measurement Information System (PROMIS) provides generalizable and universal measures of various domains of patient reported outcomes. The PROMIS-57 and PROMIS-29…
2018 American Transplant Congress
Incidence of Epstein Barr Virus (EBV) DNAemia in EBV-Seronegative Solid Organ Transplant (SOT) Recipients with EBV-Seropositive Donors
C. Burton,¹ C. Mabilangan,² J. Preiksaitis.²
¹Pediatrics, University of Alberta, Edmonton, Canada; ²Medicine, University of Alberta, Edmonton, Canada.
Purpose: Since 2002, a pre-emptive approach to post-transplant lymhoproliferative disease prevention has been used at our center that includes EBV viral load (VL) monitoring in…
2018 American Transplant Congress
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
A. Osband, J. Machan, P. Morrissey.
Surgery, Alpert Medical School of Brown University, Providence, RI.
Background: With widespread adoption of EHR (electronic health record), patients have access to a patient portal where they can view and thereby help monitor their…
2017 American Transplant Congress
Donor-Derived Cell-Free DNA Correlates with Antibody-Mediated Rejection in Kidney Allografts.
R. Bloom,¹ J. Bromberg,² E. Poggio,³ D. Hiller,⁴ R. Woodward,⁴ J. Sninsky,⁴ J. Yee,⁴ D. Brennan.⁵
¹University of Pennsylvania, Philadelphia, PA; ²University of Maryland, Baltimore, MD; ³Cleveland Clinic, Cleveland, OH; ⁴CareDx, Brisbane, CA; ⁵Washington University, St. Louis, MO
Purpose: Donor-derived cell-free DNA (dd-cfDNA) is a noninvasive test of allograft injury that may enable more frequent, quantitative, and safer assessment of allograft rejection and…
2017 American Transplant Congress
Elevated Circulating AT1R Levels Indicate Heightened Risk for Antibody Mediated Rejection and Graft Failure.
P. Kimball, G. Gupta, F. McDougan.
Transplant Surgery, VCUHealth Systems, Richmond, VA
Background.Antibody(Ab) against the angiotensin II receptor(AT1R) can cause antibody mediated rejection(AMR) and graft failure after transplantation. We evaluated whether circulating AT1R is a potential marker…
2017 American Transplant Congress
Defining a BKV Cutt-Off and Profile for Early Detection of BKV Associated Nephropathy.
C. Nihei,¹ F. Agena,¹ F. Paula,¹ D. David,¹ M. Fink,³ L. Pierrotti,² E. David-Neto.¹
¹Renal Transplantation Service, Universidade de São Paulo, São Paulo, SP, Brazil; ²Parasitic and Infectious Diseases Division, Universidade de São Paulo, São Paulo, SP, Brazil; ³Tropical Medicine Institute, Universidade de São Paulo, São Paulo, SP, Brazil
BK polyomavirus-associated nephropathy (BKPyVAN) represents a challenge to transplant centers. Prevention using early detection of BKPy viremia (BKPyV) and immunosuppression(IS) reduction is the best current…
2017 American Transplant Congress
Assessment of a Medication Education Program Among New Transplant Recipients at a Large Academic Health Center.
G. Meadows,¹ J. Kyle,¹ A. Dodson,¹ K. Gutierrez,¹ P. MacLennan,² F. Iqbal,² L. Weldon,¹ D. Jones,¹ A. James.¹
¹Department of Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, AL; ²Division of Transplantation, University of Alabama at Birmingham, Birmingham, AL
To help patients understand their medications and for adjustment post-transplant, we have implemented a self-medication (self-meds) program as a method of teaching patients their medications…
2017 American Transplant Congress
Cytomegalovirus Viral Load: Characterization of Results from Clinical Specimens.
S. Kleiboeker.
Viracor Eurofins, Lees Summit, MO
Cytomegalovirus (CMV) infection, a frequent complication affecting solid organ and hematopoietic stem cell transplant recipients, is commonly diagnosed and monitored by quantitative PCR (qPCR) methods.…
2017 American Transplant Congress
A Novel Microsurgical Penis Transplant Model to Study Distinct Immunologic Features of Urogenital Tissues.
G. Furtmüller, S. Fidder, B. Simons, B. Oh, B. Kern, D. Lough, M. Chicco, C. Brayton, W. Lee, D. Cooney, R. Redett, G. Brandacher.
Johns Hopkins University, Baltimore, MD
Background: Penis transplantation has been successfully employed in the recent past and represents an exciting avenue for restoration of male urogenitalia and function by using…
2017 American Transplant Congress
Donor-Derived Cell-Free DNA Is a Dynamic Biomarker of Active Rejection in Kidney Allografts.
D. Brennan,¹ J. Bromberg,² E. Poggio,³ D. Hiller,⁴ J. Sninsky,⁴ R. Woodward,⁴ J. Yee,⁴ R. Bloom.⁵
¹Washington University, St. Louis, MO; ²University of Maryland, Baltimore, MD; ³Cleveland Clinic, Cleveland, OH; ⁴CareDx, Brisbane, CA; ⁵University of Pennsylvania, Philadelphia, PA
Purpose: Donor-derived cell-free DNA (dd-cfDNA) has shown promise as a biomarker in identification of allograft rejection. Here we report on the changes in dd-cfDNA prior…